Arenicin-1 vs IGF-1 LR3

Head-to-head comparison of Arenicin-1 (Arenicin-1) and IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArenicin-1IGF-1 LR3
CategoryMarine-DerivedPerformance
Full NameArenicin-1Insulin-like Growth Factor-1 Long R3
Molecular Weight2079 Da9,117 Da
Half-Lifen/a~20-30 hours
Amino Acids2183
Typical Dosen/a20-100 mcg
RoutepreclinicalIM / SC
Purity≥98%
Studies Count76298
Research StatusPre-clinicalPre-clinical

Arenicin-1 Benefits

  • antimicrobial
  • anti-biofilm
  • membrane-active

IGF-1 LR3 Benefits

  • Promotes muscle hyperplasia (new muscle cells)
  • Extended half-life vs native IGF-1
  • Enhanced protein synthesis
  • Improved nutrient partitioning
  • Anti-catabolic effects

Arenicin-1 Dosing

bacterial infection|biofilm disruption

IGF-1 LR3 Dosing

Standard: 20-50 mcg IM post-workout|Advanced: 50-100 mcg IM or SC daily|Cycle: 4-6 weeks on, 4 weeks off

Arenicin-1 Side Effects

  • Arenicola marina

IGF-1 LR3 Side Effects

  • Common: Hypoglycemia (dose-dependent), joint pain, water retention
  • Moderate: Gut growth concern (high doses), acromegaly-like symptoms
  • Serious: Theoretical cancer risk (prolonged high-dose use)

Research Overview

Arenicin-1

Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.

IGF-1 LR3

IGF-1 LR3 has extensive in vitro and animal data. Its role in muscle hyperplasia is well-documented. The extended half-life modification provides practical advantages over native IGF-1.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Arenicin-1 stacks with:

Arenicola marinabeta-hairpinantibiotic

IGF-1 LR3 stacks with:

BPC-157TB-500CJC-1295
marine-derivedbioactiveantimicrobial peptidebiofilmMuscle GrowthAnti-agingPerformanceAnabolic